Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Neurodegenerative disorders and cholesterol.

Makoto Michikawa1

  • 1Department of Alzheimer's Disease Research, National Institute for Longevity Sciences, 36-3 Gengo, Obu, Aichi 474-8522, Japan. michi@nils.go.jp

Current Alzheimer Research
|June 25, 2005
PubMed
Summary

Low high-density lipoprotein (HDL) levels, not high cholesterol, may be a risk factor for Alzheimer's disease (AD). This review explores cholesterol's complex role in AD pathogenesis and potential links to Niemann-Pick type C disease.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Elevated Flotillin-1 in Saliva and Salivary Glands: A Novel Non-Invasive Biomarker in an Alzheimer's Disease Mouse Model.

Diagnostics (Basel, Switzerland)·2026
Same author

Protective Effects of Bifidobacterium Breve MCC1274 as a Novel Therapy for Alzheimer's Disease.

Nutrients·2025
Same author

Multi-functional role of apolipoprotein E in neurodegenerative diseases.

Frontiers in aging neuroscience·2025
Same author

Presenilin deficiency enhances tau phosphorylation and its secretion.

Journal of neurochemistry·2024
Same author

Japan-Multimodal Intervention Trial for the Prevention of Dementia: A randomized controlled trial.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2024
Same author

Potential Therapeutic Effects of <i>Bifidobacterium breve</i> MCC1274 on Alzheimer's Disease Pathologies in <i>App</i> Mice.

Nutrients·2024

Area of Science:

  • Neuroscience
  • Biochemistry
  • Genetics

Background:

  • High serum cholesterol was previously considered a risk factor for Alzheimer's disease (AD).
  • Statins and genetic polymorphisms in cholesterol metabolism were thought to influence AD development.
  • Recent findings challenge these established notions regarding cholesterol and AD.

Purpose of the Study:

  • To propose a new hypothesis: low high-density lipoprotein (HDL) levels in serum and cerebrospinal fluid (CSF) as a risk factor for AD.
  • To explore the potential shared pathomechanisms between AD and Niemann-Pick type C disease.
  • To discuss the association between cholesterol metabolism and neurodegeneration in AD from multiple perspectives.

Main Methods:

  • Literature review and synthesis of existing research on cholesterol metabolism and AD.

Related Experiment Videos

  • Analysis of recent studies challenging conventional hypotheses.
  • Discussion of proposed alternative mechanisms and shared pathways.

    • Main Results:

    • Evidence suggests that low HDL levels may be a significant risk factor for AD development.
    • Altered cholesterol metabolism could be implicated in neurodegeneration, potentially linking AD and Niemann-Pick type C disease.
    • The precise mechanism of cholesterol's involvement in AD pathogenesis remains unclear but is actively being investigated.

    Conclusions:

    • A low HDL cholesterol level is proposed as a potential risk factor for Alzheimer's disease.
    • Shared pathobiological cascades involving cholesterol metabolism may link AD and Niemann-Pick type C disease.
    • Further research is needed to elucidate the complex relationship between cholesterol and AD pathogenesis.